WINT News and Press, Windtree Therapeutics Inc. From 03/29/21

Windtree Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides Key Business Updates PR Newswire WARRINGTON, Pa. , March 29, 2021 /PRNewswire/ -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device c...

Windtree Therapeutics Announces Closing of $30.0 Million Public Offering PR Newswire WARRINGTON, Pa. , March 25, 2021 /PRNewswire/ -- Windtree Therapeutics, Inc. (NasdaqCM: WINT) ("Windtree" or the "Company"), a biotechnology and medical device company focus...

Gainers: Dolphin Entertainment (DLPN) +163%.Benitec Biopharma (BNTC) +88%.Liquid Media (YVR) +51%.Takung Art (TKAT) +35%.Evolve Transition Infrastructure (SNMP) +27%.Genius Brands International (GNUS) +17%.The ONE Group Hospitality (STKS) +17%.Glory Star New Media (GSMG) +16%.Funko ...

Windtree Therapeutics ([[WINT]] -27.4%) priced its earlier announced public offering of 9.23M shares, par value $0.001 per share, together with warrants at $3.25/share.Each warrant, exercisable immediately, will have an exercise price of $3.60/share with five years expiry on issuance date.Exp...

Gainers: Benitec Biopharma (BNTC) +71%, Hoth Therapeutics (HOTH) +26%, Aerpio Pharmaceuticals (ARPO) +12%, Soliton (SOLY) +11%, China Jo-Jo Drugstores (CJJD) +9%.Losers: Frequency Therapeutics (FREQ) -75%, Windtree Therapeutics (WINT) ...

Frequency Therapeutics (FREQ) -71% after releases new data. from two FX-322 clinical studies; plans to advance single-dose regimen.Anixa Biosciences (ANIX) -23% after raises previously announced bought deal offering of common stock to $22.5M.Windtree Therapeutics (WIN...

Windtree Therapeutics Announces Pricing of $30.0 Million Public Offering PR Newswire WARRINGTON, Pa. , March 23, 2021 /PRNewswire/ -- Windtree Therapeutics, Inc. (NasdaqCM: WINT) ("Windtree" or the "Company"), a biotechnology and medical device company focus...

Windtree Therapeutics (WINT) trades 12.2% down after hours on commencing an underwritten public offering of its shares and warrants.Offer size, terms have not yet been disclosed.Net proceeds along with other available funds to be used for the continued advancement of its lead p...

Windtree Therapeutics Announces Proposed Public Offering of Common Stock and Warrants PR Newswire WARRINGTON, Pa. , March 22, 2021 /PRNewswire/ -- Windtree Therapeutics, Inc. (NasdaqCM: WINT) ("Windtree" or the "Company"), a biotechnology and medical device ...

Windtree Extends Scientific Collaboration in Heart Failure Studying Its SERCA2a Activators with the University of Milan-Bicocca Collaboration to focus on the continued development of chronic heart failure treatment SERCA2a activator compounds adding to Windtree's acute treatment...